Workflow
特种产品饲料添加剂
icon
Search documents
安迪苏不超30亿定增获上交所通过 中信证券建功
Zhong Guo Jing Ji Wang· 2025-08-08 01:48
中国经济网北京8月8日讯据上交所网站消息,蓝星安迪苏(600299)股份有限公司(上市公司代码:600299,上市公司简称:安迪苏)主板再融资于2025年8 月7日获得上交所审核通过。 | 上市公司全称 | 蓝星安迪苏股份有限公司 | 上市公司简称/ 扩位简称 | 安迪苏/- | | --- | --- | --- | --- | | 上市公司代码 | 600299 | 再融资方式 | 非公开发行股票 | | 融资金额(亿元) | 30.00 | 受理日期 | 2025-04-15 | | 审核状态 | 通过 | 更新日期 | 2025-08-07 | | 保荐机构 | 中信证券股份有限公司 | 保荐代表人 | 潘杰克,黄艺彬 | | 会计师事务所 | 毕马威华振会计师事务所(特殊普通合伙) | 签字会计师 | 张欢,王姗,林莹 | | 律师事务所 | 北京市金杜律师事务所 | 签字律师 | 陈复安,王宁远,宋方成 | 2025年4月17日,安迪苏发布的向特定对象发行A股股票募集说明书(申报稿)显示,本次发行A股股票的募集资金总额(含发行费用)不超过30.00亿元(含本 数),扣除发行费用后的募集资金净额将用 ...
安迪苏: 毕马威华振会计师事务所(特殊普通合伙)关于蓝星安迪苏股份有限公司向特定对象发行股票申请文件的审核问询函回复的专项说明
Zheng Quan Zhi Xing· 2025-06-26 16:20
Core Viewpoint - Blue Star Adisseo Co., Ltd. is seeking to raise funds through a specific stock issuance, with a total investment of 6.857 billion yuan for four projects and working capital, aiming for an internal rate of return between 13.57% and 25% [2][3]. Fundraising and Investment Projects - The total investment for the fundraising projects is 6.857 billion yuan, with a maximum of 3 billion yuan to be raised, allocated to four projects and 900 million yuan for working capital [2]. - The construction period for the four projects ranges from 15 to 26 months, with expected benefits from cost reductions and additional income from biogas [2]. Project Details - The first project is a solid methionine production project with an investment of approximately 493.23 million yuan, accounting for 100% of the total investment for this project [3][4]. - The second project involves a special feed additive with a total investment of 304.97 million yuan, with 60 million yuan sourced from the fundraising [11]. - The third project focuses on acrylic wastewater treatment and water reuse, with a total investment of 324.97 million yuan and 100 million yuan from the fundraising [15][19]. Cost Estimation and Reasonableness - The cost estimation for the solid methionine project is based on market prices and relevant cost estimation methods, ensuring its reasonableness [4][5]. - The unit construction cost for the solid methionine project is 3,593.25 yuan per square meter, which is within the range of similar projects in the region [7][12]. - The equipment costs for the projects are estimated based on supplier quotes and historical prices, ensuring that the pricing is reasonable [13][14]. Financial Justification - The financing scale is justified by the company's operational needs, cash flow, and projected funding gaps, with a future funding shortfall of approximately 5.566 billion yuan over the next three years [19].
安迪苏: 北京市金杜律师事务所关于蓝星安迪苏股份有限公司向特定对象发行A股股票的补充法律意见书
Zheng Quan Zhi Xing· 2025-06-26 16:20
Core Viewpoint - The document outlines the legal opinions and supplementary legal advice provided by King & Wood Mallesons regarding Blue Star Adisseo Co., Ltd.'s issuance of A-shares to specific targets, emphasizing compliance with Chinese laws and regulations [1][2][3]. Group 1: Issuance Details - The issuance includes projects such as a 150,000 tons/year solid methionine project and a 37,000 tons/year specialty feed additive project, among others [4][5]. - The company has not yet obtained the necessary overseas investment filing for the Burgos specialty feed additive project [4][5]. Group 2: Legal Compliance - The law firm confirms that it only provides opinions on Chinese legal matters and does not assess non-legal professional matters such as finance or accounting [3][4]. - The supplementary legal opinion is an integral part of the previously issued legal documents and maintains the same assumptions and premises [2][4]. Group 3: Overseas Investment - The overseas investment project is to be implemented by the company's subsidiary in Spain, focusing on specialty feed additives [7][8]. - The company has submitted the necessary overseas investment filing to the Ministry of Commerce, and there are no significant legal uncertainties expected regarding this process [10][12]. Group 4: Financial Assistance - The company has provided financial assistance to its joint venture, Calysseo, to support the construction of a facility for producing single-cell protein, which is strategically aligned with its core business [15][16]. - The financial assistance provided does not constitute a related party transaction under the Shanghai Stock Exchange rules [17][18].